Chemomab Therapeutics (CMMB) Consolidated Net Income (2017 - 2026)
Chemomab Therapeutics' Consolidated Net Income was $2.17 million in Q2 2026, up 5.3% from $2.06 million a year earlier and up 22.1% from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Consolidated Net Income (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Chemomab Therapeutics' Consolidated Net Income was $7.55 million through Jun 30, 2026, down 36.1% year-over-year; for FY2025, it came in at $9 million, down 35.5% from FY2024.
- Consolidated Net Income has now declined for three consecutive years, with a four-year compound annual growth rate of -7.9% (FY2021 to FY2025).
- In earlier years, Consolidated Net Income was $13.95 million in FY2024 (-42.4%), $24.22 million in FY2023 (-15.6%), $28.71 million in FY2022 (+130.1%) and $12.48 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Consolidated Net Income since Q1 2025.
- Compared with a year earlier, Consolidated Net Income was higher in 1 of the last eight quarters, with an average decline of 27.0%.
- The best year-over-year quarter for Consolidated Net Income over five years was Q2 2023 (growth of 8.6%); the worst was Q4 2023 (a decline of 58.6%).
- Per Business Quant data, CMMB's Consolidated Net Income in the three quarters before Q2 2026 was $1.77 million (Q1 2026), $1.87 million (Q4 2025) and $1.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Chemomab Therapeutics | 10.28 Mn | 10.28 Mn | - | 2.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.17 Mn |
| Mar 31, 2026 | 1.77 Mn |
| Dec 31, 2025 | 1.87 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 2.06 Mn |
| Mar 31, 2025 | 3.32 Mn |
| Dec 31, 2024 | 2.96 Mn |
| Sep 30, 2024 | 3.48 Mn |
| Jun 30, 2024 | 3.63 Mn |
| Mar 31, 2024 | 3.87 Mn |
| Dec 31, 2023 | 3.42 Mn |
| Sep 30, 2023 | 4.19 Mn |
| Jun 30, 2023 | 7.90 Mn |
| Mar 31, 2023 | 8.71 Mn |
| Dec 31, 2022 | 8.25 Mn |
| Sep 30, 2022 | 8.08 Mn |
| Jun 30, 2022 | 7.28 Mn |
| Mar 31, 2022 | -5.10 Mn |
| Dec 31, 2021 | 19.92 Mn |
| Sep 30, 2021 | -2.97 Mn |
API Access
Chemomab Therapeutics Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();